Benefits of Levonorgestrel Intrauterine Device Use vs. Oral or Transdermal Progesterone for Postmenopausal Women Using Estrogen Containing Hormone Therapy
Background: Endometrial hyperplasia is a major concern for women that start estrogen replacement therapy (ERT) to control symptoms experienced during perimenopause and postmenopause. Progesterone provides protection against endometrial hyperplasia, and there are multiple dosage forms of progesteron...
Saved in:
Main Authors: | Kaylee Clark (Author), Sarah M. Westberg (Author) |
---|---|
Format: | Book |
Published: |
University of Minnesota Libraries Publishing,
2019-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacoeconomic advantages of using intrauterine levonorgestrel containing Mirena system in conjunction with the transdermal estrogen containing drugs for the treatment of menopausal syndrome and contraception during the menopausal transition
by: N G Baeva, et al.
Published: (2016) -
Decision-making regarding immediate vs. interval postpartum levonorgestrel intrauterine device insertion timing
by: Abigail Davenport, et al.
Published: (2023) -
The levonorgestrel intrauterine device in Australia: analysis of prescribing data 2008-2012
by: Amie L. Bingham, et al.
Published: (2018) -
Is chronic pelvic pain or heavy menstrual bleeding the main target beneficial to the use of levonorgestrel intrauterine devices?
by: Szu-Ting Yang, et al.
Published: (2023) -
Effects of Levonorgestrel and progesterone on Oviductal physiology in mammals
by: Cheng Li, et al.
Published: (2018)